Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of cell killing (GO:0031342) | 6.63965404 |
2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.63965404 |
3 | tolerance induction (GO:0002507) | 6.25775339 |
4 | response to muramyl dipeptide (GO:0032495) | 4.44950271 |
5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.29273080 |
6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.24144331 |
7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.24144331 |
8 | regulation of germinal center formation (GO:0002634) | 4.17826892 |
9 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.95153281 |
10 | neutrophil activation (GO:0042119) | 3.94851095 |
11 | negative regulation of T cell mediated immunity (GO:0002710) | 3.89777102 |
12 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.89273282 |
13 | positive T cell selection (GO:0043368) | 3.77040363 |
14 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.74276704 |
15 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.69765765 |
16 | thymic T cell selection (GO:0045061) | 3.68616583 |
17 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.67413080 |
18 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.66495757 |
19 | leukocyte aggregation (GO:0070486) | 3.66489765 |
20 | T cell selection (GO:0045058) | 3.65089668 |
21 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.64856734 |
22 | regulation of regulatory T cell differentiation (GO:0045589) | 3.64724415 |
23 | negative regulation of innate immune response (GO:0045824) | 3.61096268 |
24 | immunoglobulin mediated immune response (GO:0016064) | 3.56378296 |
25 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.51639321 |
26 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.48735009 |
27 | granulocyte activation (GO:0036230) | 3.44254731 |
28 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.43962087 |
29 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.38167945 |
30 | sleep (GO:0030431) | 3.33419125 |
31 | interferon-gamma production (GO:0032609) | 3.32795046 |
32 | positive regulation of granulocyte differentiation (GO:0030854) | 3.31312952 |
33 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.30842762 |
34 | dendritic cell chemotaxis (GO:0002407) | 3.30649751 |
35 | L-phenylalanine catabolic process (GO:0006559) | 3.29271276 |
36 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.29271276 |
37 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.27572989 |
38 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.21966112 |
39 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.21393906 |
40 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.20813238 |
41 | T cell migration (GO:0072678) | 3.20231368 |
42 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.20141283 |
43 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.19863244 |
44 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.19863244 |
45 | RNA destabilization (GO:0050779) | 3.15197011 |
46 | leukocyte degranulation (GO:0043299) | 3.10580461 |
47 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.09984108 |
48 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.09984108 |
49 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.09621305 |
50 | T-helper cell differentiation (GO:0042093) | 3.09536530 |
51 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.09536530 |
52 | T cell receptor signaling pathway (GO:0050852) | 3.08570429 |
53 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.02796701 |
54 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.01966651 |
55 | regulation of antigen processing and presentation (GO:0002577) | 3.01489429 |
56 | regulation of cell killing (GO:0031341) | 3.00594551 |
57 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.00423884 |
58 | dendritic cell migration (GO:0036336) | 2.99832358 |
59 | L-phenylalanine metabolic process (GO:0006558) | 2.99553625 |
60 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.99553625 |
61 | regulation of T cell mediated immunity (GO:0002709) | 2.96779213 |
62 | regulation of mast cell degranulation (GO:0043304) | 2.95492625 |
63 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.95417431 |
64 | mast cell degranulation (GO:0043303) | 2.95397516 |
65 | mast cell activation involved in immune response (GO:0002279) | 2.95397516 |
66 | complement activation, alternative pathway (GO:0006957) | 2.94342079 |
67 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.94009798 |
68 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.93702885 |
69 | Peyers patch development (GO:0048541) | 2.93702885 |
70 | alpha-beta T cell differentiation (GO:0046632) | 2.93519124 |
71 | negative regulation of bone resorption (GO:0045779) | 2.91081911 |
72 | positive regulation of T cell mediated immunity (GO:0002711) | 2.89327178 |
73 | B cell homeostasis (GO:0001782) | 2.88914692 |
74 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.88818355 |
75 | B cell mediated immunity (GO:0019724) | 2.86164625 |
76 | myeloid cell activation involved in immune response (GO:0002275) | 2.85950367 |
77 | defense response to protozoan (GO:0042832) | 2.85821188 |
78 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.85733870 |
79 | positive regulation of B cell differentiation (GO:0045579) | 2.85489456 |
80 | activated T cell proliferation (GO:0050798) | 2.83546976 |
81 | alpha-beta T cell activation (GO:0046631) | 2.83094041 |
82 | regulation of alpha-beta T cell activation (GO:0046634) | 2.80581229 |
83 | regulation of mast cell activation (GO:0033003) | 2.80483210 |
84 | positive regulation of mast cell activation (GO:0033005) | 2.80073021 |
85 | modulation by symbiont of host immune response (GO:0052553) | 2.79667870 |
86 | positive regulation by symbiont of host defense response (GO:0052509) | 2.79667870 |
87 | modulation by symbiont of host defense response (GO:0052031) | 2.79667870 |
88 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.79667870 |
89 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.79667870 |
90 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.79667870 |
91 | positive regulation of respiratory burst (GO:0060267) | 2.78032610 |
92 | alpha-linolenic acid metabolic process (GO:0036109) | 2.73971177 |
93 | aromatic amino acid family catabolic process (GO:0009074) | 2.71984436 |
94 | B cell receptor signaling pathway (GO:0050853) | 2.71446465 |
95 | valine metabolic process (GO:0006573) | 2.63469364 |
96 | regulation of gamma-delta T cell activation (GO:0046643) | 2.61286997 |
97 | regulation of protein activation cascade (GO:2000257) | 2.59509907 |
98 | regulation of complement activation (GO:0030449) | 2.59269272 |
99 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.57891679 |
100 | regulation of B cell differentiation (GO:0045577) | 2.57066801 |
101 | negative regulation of humoral immune response (GO:0002921) | 2.54267543 |
102 | negative regulation of complement activation (GO:0045916) | 2.52903393 |
103 | phospholipid efflux (GO:0033700) | 2.50061203 |
104 | complement activation (GO:0006956) | 2.49221068 |
105 | negative regulation of protein activation cascade (GO:2000258) | 2.48400420 |
106 | negative regulation of protein autophosphorylation (GO:0031953) | 2.46702358 |
107 | complement activation, classical pathway (GO:0006958) | 2.45623078 |
108 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.42365893 |
109 | regulation of triglyceride catabolic process (GO:0010896) | 2.41806395 |
110 | indole-containing compound catabolic process (GO:0042436) | 2.40994952 |
111 | indolalkylamine catabolic process (GO:0046218) | 2.40994952 |
112 | tryptophan catabolic process (GO:0006569) | 2.40994952 |
113 | very long-chain fatty acid metabolic process (GO:0000038) | 2.40419296 |
114 | cellular extravasation (GO:0045123) | 2.39022352 |
115 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.38995229 |
116 | amyloid precursor protein catabolic process (GO:0042987) | 2.37560356 |
117 | low-density lipoprotein particle remodeling (GO:0034374) | 2.36378272 |
118 | regulation of humoral immune response (GO:0002920) | 2.35378811 |
119 | negative T cell selection (GO:0043383) | 2.35033413 |
120 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.34630426 |
121 | surfactant homeostasis (GO:0043129) | 2.34446726 |
122 | ethanol oxidation (GO:0006069) | 2.32808757 |
123 | negative thymic T cell selection (GO:0045060) | 2.31984267 |
124 | definitive hemopoiesis (GO:0060216) | 2.30380030 |
125 | creatine metabolic process (GO:0006600) | 2.30295252 |
126 | bile acid biosynthetic process (GO:0006699) | 2.28249703 |
127 | regulation of cholesterol esterification (GO:0010872) | 2.26370394 |
128 | fatty acid catabolic process (GO:0009062) | 2.26320906 |
129 | fatty acid beta-oxidation (GO:0006635) | 2.26197667 |
130 | membrane raft organization (GO:0031579) | 2.25875012 |
131 | lipid oxidation (GO:0034440) | 2.25580976 |
132 | response to interleukin-15 (GO:0070672) | 2.25571224 |
133 | response to laminar fluid shear stress (GO:0034616) | 2.25248805 |
134 | positive regulation of antigen processing and presentation (GO:0002579) | 2.23759939 |
135 | regulation of T cell tolerance induction (GO:0002664) | 2.23609609 |
136 | fatty acid oxidation (GO:0019395) | 2.23430615 |
137 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.22495223 |
138 | regulation of relaxation of muscle (GO:1901077) | 2.21929613 |
139 | kynurenine metabolic process (GO:0070189) | 2.20295472 |
140 | opsonization (GO:0008228) | 2.19618606 |
141 | response to mercury ion (GO:0046689) | 2.18818749 |
142 | neutrophil activation involved in immune response (GO:0002283) | 2.18479099 |
143 | detection of bacterium (GO:0016045) | 2.17744910 |
144 | cellular response to interleukin-15 (GO:0071350) | 2.17148752 |
145 | tryptophan metabolic process (GO:0006568) | 2.17065654 |
146 | protein activation cascade (GO:0072376) | 2.16623147 |
147 | detection of other organism (GO:0098543) | 2.16590961 |
148 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.14687361 |
149 | fatty acid elongation (GO:0030497) | 2.13443221 |
150 | blood vessel maturation (GO:0001955) | 2.13367432 |
151 | positive thymic T cell selection (GO:0045059) | 2.11466300 |
152 | monocarboxylic acid catabolic process (GO:0072329) | 2.10702351 |
153 | mature B cell differentiation involved in immune response (GO:0002313) | 2.09635760 |
154 | regulation of respiratory burst (GO:0060263) | 2.07972798 |
155 | regulation of cholesterol metabolic process (GO:0090181) | 2.07942666 |
156 | fatty acid transmembrane transport (GO:1902001) | 2.07118038 |
157 | mature B cell differentiation (GO:0002335) | 2.05809273 |
158 | negative regulation of lipase activity (GO:0060192) | 2.05431550 |
159 | keratan sulfate catabolic process (GO:0042340) | 2.03378855 |
160 | regulation of extracellular matrix disassembly (GO:0010715) | 2.02479437 |
161 | angiogenesis involved in wound healing (GO:0060055) | 2.02170737 |
162 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.01770460 |
163 | protein carboxylation (GO:0018214) | 2.01770460 |
164 | ethanol metabolic process (GO:0006067) | 2.00968779 |
165 | regulation of cholesterol biosynthetic process (GO:0045540) | 1.99508583 |
166 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 1.99140834 |
167 | mast cell activation (GO:0045576) | 1.99092610 |
168 | 2-oxoglutarate metabolic process (GO:0006103) | 1.98630259 |
169 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 1.98356125 |
170 | macrophage differentiation (GO:0030225) | 1.97220307 |
171 | high-density lipoprotein particle remodeling (GO:0034375) | 1.96755457 |
172 | reverse cholesterol transport (GO:0043691) | 1.96651050 |
173 | positive regulation of sterol transport (GO:0032373) | 1.96269042 |
174 | positive regulation of cholesterol transport (GO:0032376) | 1.96269042 |
175 | lymph vessel development (GO:0001945) | 1.95829516 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.13652831 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.79605938 |
3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.68684601 |
4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.06182077 |
5 | GATA1_22025678_ChIP-Seq_K562_Human | 2.86001717 |
6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.66258160 |
7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.65156111 |
8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.60487108 |
9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.42227980 |
10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.36089114 |
11 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.30958020 |
12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.24958919 |
13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.22648771 |
14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.16606381 |
15 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.15905331 |
16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.15223557 |
17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.14461342 |
18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.10599450 |
19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.07031612 |
20 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.00479579 |
21 | MYC_22102868_ChIP-Seq_BL_Human | 1.98095349 |
22 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.96730464 |
23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.94537688 |
24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82985057 |
25 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.82384639 |
26 | MAF_26560356_Chip-Seq_TH2_Human | 1.80561844 |
27 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77276478 |
28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.75737731 |
29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.75643933 |
30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.67036927 |
31 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.65849681 |
32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.60110130 |
33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.56638228 |
34 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.54980782 |
35 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.52693390 |
36 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.47477529 |
37 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.44819785 |
38 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43325679 |
39 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42898557 |
40 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.42183211 |
41 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.40473784 |
42 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.37180669 |
43 | MAF_26560356_Chip-Seq_TH1_Human | 1.36509871 |
44 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.35414593 |
45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35056293 |
46 | GATA1_19941826_ChIP-Seq_K562_Human | 1.34958109 |
47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.33963554 |
48 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.32303522 |
49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.32004946 |
50 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.31469441 |
51 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30212607 |
52 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.29949893 |
53 | GATA2_19941826_ChIP-Seq_K562_Human | 1.29903800 |
54 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.28864741 |
55 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.27944783 |
56 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.27451242 |
57 | MYB_26560356_Chip-Seq_TH2_Human | 1.26977199 |
58 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.24093108 |
59 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.23311672 |
60 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.22524894 |
61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.21170799 |
62 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.20077262 |
63 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17592620 |
64 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.16826905 |
65 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15214864 |
66 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.14948744 |
67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12606775 |
68 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11799596 |
69 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.11573695 |
70 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11274005 |
71 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11098674 |
72 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.10951053 |
73 | SPI1_23127762_ChIP-Seq_K562_Human | 1.10613758 |
74 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.10113434 |
75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.07824186 |
76 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07382849 |
77 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06811333 |
78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06045028 |
79 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05310229 |
80 | MYB_26560356_Chip-Seq_TH1_Human | 1.04898346 |
81 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.04770894 |
82 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.03419496 |
83 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02844735 |
84 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.02260669 |
85 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01808690 |
86 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.01733547 |
87 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.00471470 |
88 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.00161825 |
89 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98571998 |
90 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97969767 |
91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97412139 |
92 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96827248 |
93 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95852975 |
94 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95700421 |
95 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95592534 |
96 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.95471908 |
97 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95410582 |
98 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.94000374 |
99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93457908 |
100 | P300_27268052_Chip-Seq_Bcells_Human | 0.93439157 |
101 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.92340857 |
102 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91941658 |
103 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91919555 |
104 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91850502 |
105 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.89481598 |
106 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.88919812 |
107 | UTX_26944678_Chip-Seq_JUKART_Human | 0.88596256 |
108 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88190778 |
109 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88190778 |
110 | CJUN_26792858_Chip-Seq_BT549_Human | 0.87866869 |
111 | GATA3_26560356_Chip-Seq_TH2_Human | 0.86357553 |
112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86129336 |
113 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.85222722 |
114 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85179261 |
115 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.84504990 |
116 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.84233631 |
117 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.83712985 |
118 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.83541780 |
119 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83521422 |
120 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.82566701 |
121 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.81257856 |
122 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.81073318 |
123 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.80796861 |
124 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.80796861 |
125 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.80692563 |
126 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.79620093 |
127 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.79036353 |
128 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78852713 |
129 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.78808340 |
130 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.77959041 |
131 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.77951514 |
132 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.75151494 |
133 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.74414061 |
134 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.74110043 |
135 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.73781858 |
136 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.73639457 |
137 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.72855246 |
138 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.72815674 |
139 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.72575402 |
140 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.72569910 |
141 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.71753116 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 2.89172239 |
2 | MP0003191_abnormal_cellular_cholesterol | 2.87309563 |
3 | MP0002009_preneoplasia | 2.62410764 |
4 | MP0002139_abnormal_hepatobiliary_system | 2.58666431 |
5 | MP0003724_increased_susceptibility_to | 2.54787589 |
6 | MP0002837_dystrophic_cardiac_calcinosis | 2.32475340 |
7 | MP0000685_abnormal_immune_system | 2.24645985 |
8 | MP0005671_abnormal_response_to | 2.24200274 |
9 | MP0001790_abnormal_immune_system | 2.20764141 |
10 | MP0005387_immune_system_phenotype | 2.20764141 |
11 | MP0010368_abnormal_lymphatic_system | 2.20341845 |
12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.18023366 |
13 | MP0005360_urolithiasis | 2.15371792 |
14 | MP0005365_abnormal_bile_salt | 2.11031863 |
15 | MP0003436_decreased_susceptibility_to | 1.99635509 |
16 | MP0001800_abnormal_humoral_immune | 1.97008394 |
17 | MP0009785_altered_susceptibility_to | 1.88747352 |
18 | MP0005085_abnormal_gallbladder_physiolo | 1.88715591 |
19 | MP0000703_abnormal_thymus_morphology | 1.85286394 |
20 | MP0003866_abnormal_defecation | 1.81415946 |
21 | MP0002933_joint_inflammation | 1.80958701 |
22 | MP0005464_abnormal_platelet_physiology | 1.80534098 |
23 | MP0009840_abnormal_foam_cell | 1.76625678 |
24 | MP0002419_abnormal_innate_immunity | 1.76336638 |
25 | MP0005058_abnormal_lysosome_morphology | 1.72504979 |
26 | MP0003279_aneurysm | 1.70443852 |
27 | MP0009333_abnormal_splenocyte_physiolog | 1.69502972 |
28 | MP0001853_heart_inflammation | 1.68048750 |
29 | MP0010329_abnormal_lipoprotein_level | 1.67936795 |
30 | MP0005075_abnormal_melanosome_morpholog | 1.67429007 |
31 | MP0002452_abnormal_antigen_presenting | 1.66647379 |
32 | MP0005000_abnormal_immune_tolerance | 1.65134724 |
33 | MP0005025_abnormal_response_to | 1.62110647 |
34 | MP0003690_abnormal_glial_cell | 1.61970759 |
35 | MP0001879_abnormal_lymphatic_vessel | 1.61509937 |
36 | MP0001873_stomach_inflammation | 1.60598381 |
37 | MP0002138_abnormal_hepatobiliary_system | 1.60510100 |
38 | MP0000465_gastrointestinal_hemorrhage | 1.57770001 |
39 | MP0002723_abnormal_immune_serum | 1.57479089 |
40 | MP0002166_altered_tumor_susceptibility | 1.56627265 |
41 | MP0000343_altered_response_to | 1.56620160 |
42 | MP0004036_abnormal_muscle_relaxation | 1.56466038 |
43 | MP0002148_abnormal_hypersensitivity_rea | 1.54529241 |
44 | MP0004130_abnormal_muscle_cell | 1.53277139 |
45 | MP0002420_abnormal_adaptive_immunity | 1.52691407 |
46 | MP0003763_abnormal_thymus_physiology | 1.51882976 |
47 | MP0001533_abnormal_skeleton_physiology | 1.50095784 |
48 | MP0001819_abnormal_immune_cell | 1.49464138 |
49 | MP0006082_CNS_inflammation | 1.46701205 |
50 | MP0005670_abnormal_white_adipose | 1.46031995 |
51 | MP0002254_reproductive_system_inflammat | 1.45983086 |
52 | MP0002006_tumorigenesis | 1.44168750 |
53 | MP0005167_abnormal_blood-brain_barrier | 1.40193042 |
54 | MP0003075_altered_response_to | 1.38883053 |
55 | MP0000920_abnormal_myelination | 1.33801623 |
56 | MP0004510_myositis | 1.29693636 |
57 | MP0001501_abnormal_sleep_pattern | 1.25558211 |
58 | MP0008469_abnormal_protein_level | 1.23243109 |
59 | MP0005397_hematopoietic_system_phenotyp | 1.21584028 |
60 | MP0001545_abnormal_hematopoietic_system | 1.21584028 |
61 | MP0009764_decreased_sensitivity_to | 1.20842314 |
62 | MP0000751_myopathy | 1.18967059 |
63 | MP0001845_abnormal_inflammatory_respons | 1.18820213 |
64 | MP0002396_abnormal_hematopoietic_system | 1.18794000 |
65 | MP0002118_abnormal_lipid_homeostasis | 1.18783865 |
66 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.18595283 |
67 | MP0003300_gastrointestinal_ulcer | 1.17480372 |
68 | MP0005310_abnormal_salivary_gland | 1.17057218 |
69 | MP0001764_abnormal_homeostasis | 1.16364921 |
70 | MP0001986_abnormal_taste_sensitivity | 1.15642257 |
71 | MP0003252_abnormal_bile_duct | 1.14887440 |
72 | MP0000749_muscle_degeneration | 1.14353075 |
73 | MP0003303_peritoneal_inflammation | 1.13802824 |
74 | MP0003656_abnormal_erythrocyte_physiolo | 1.13033745 |
75 | MP0005332_abnormal_amino_acid | 1.12750150 |
76 | MP0000716_abnormal_immune_system | 1.12022546 |
77 | MP0004381_abnormal_hair_follicle | 1.10740343 |
78 | MP0000249_abnormal_blood_vessel | 1.09377621 |
79 | MP0009278_abnormal_bone_marrow | 1.08439407 |
80 | MP0000609_abnormal_liver_physiology | 1.08049401 |
81 | MP0002405_respiratory_system_inflammati | 1.07749230 |
82 | MP0004147_increased_porphyrin_level | 1.07723763 |
83 | MP0004883_abnormal_blood_vessel | 1.06655615 |
84 | MP0005390_skeleton_phenotype | 1.06632327 |
85 | MP0004084_abnormal_cardiac_muscle | 1.06443176 |
86 | MP0000689_abnormal_spleen_morphology | 1.02815115 |
87 | MP0001958_emphysema | 1.01888758 |
88 | MP0010155_abnormal_intestine_physiology | 1.01758663 |
89 | MP0001666_abnormal_nutrient_absorption | 1.01282248 |
90 | MP0002132_abnormal_respiratory_system | 0.98793964 |
91 | MP0009384_cardiac_valve_regurgitation | 0.97653194 |
92 | MP0002398_abnormal_bone_marrow | 0.97454187 |
93 | MP0000858_altered_metastatic_potential | 0.97220815 |
94 | MP0001851_eye_inflammation | 0.96265023 |
95 | MP0003828_pulmonary_edema | 0.95267292 |
96 | MP0005166_decreased_susceptibility_to | 0.93399250 |
97 | MP0003172_abnormal_lysosome_physiology | 0.91251212 |
98 | MP0009763_increased_sensitivity_to | 0.89634045 |
99 | MP0008874_decreased_physiological_sensi | 0.86635051 |
100 | MP0005165_increased_susceptibility_to | 0.85908480 |
101 | MP0004947_skin_inflammation | 0.85853327 |
102 | MP0003183_abnormal_peptide_metabolism | 0.85636069 |
103 | MP0003011_delayed_dark_adaptation | 0.85602189 |
104 | MP0005164_abnormal_response_to | 0.85264042 |
105 | MP0005319_abnormal_enzyme/_coenzyme | 0.84618611 |
106 | MP0002429_abnormal_blood_cell | 0.84495881 |
107 | MP0006054_spinal_hemorrhage | 0.83482488 |
108 | MP0002998_abnormal_bone_remodeling | 0.82962810 |
109 | MP0009643_abnormal_urine_homeostasis | 0.82193769 |
110 | MP0003646_muscle_fatigue | 0.80931010 |
111 | MP0003806_abnormal_nucleotide_metabolis | 0.80733223 |
112 | MP0002722_abnormal_immune_system | 0.80639808 |
113 | MP0002277_abnormal_respiratory_mucosa | 0.80008248 |
114 | MP0002876_abnormal_thyroid_physiology | 0.79625659 |
115 | MP0000230_abnormal_systemic_arterial | 0.79448263 |
116 | MP0000604_amyloidosis | 0.78663426 |
117 | MP0008961_abnormal_basal_metabolism | 0.74895081 |
118 | MP0005666_abnormal_adipose_tissue | 0.74695467 |
119 | MP0004145_abnormal_muscle_electrophysio | 0.74248064 |
120 | MP0004484_altered_response_of | 0.73449153 |
121 | MP0006138_congestive_heart_failure | 0.72764792 |
122 | MP0008995_early_reproductive_senescence | 0.69056720 |
123 | MP0002019_abnormal_tumor_incidence | 0.68395920 |
124 | MP0003795_abnormal_bone_structure | 0.64205944 |
125 | MP0001919_abnormal_reproductive_system | 0.63036718 |
126 | MP0001765_abnormal_ion_homeostasis | 0.62870995 |
127 | MP0009765_abnormal_xenobiotic_induced | 0.61672497 |
128 | MP0003638_abnormal_response/metabolism_ | 0.61236746 |
129 | MP0001663_abnormal_digestive_system | 0.58336349 |
130 | MP0003448_altered_tumor_morphology | 0.53372987 |
131 | MP0000015_abnormal_ear_pigmentation | 0.50881633 |
132 | MP0002136_abnormal_kidney_physiology | 0.50018359 |
133 | MP0005174_abnormal_tail_pigmentation | 0.49703636 |
134 | MP0004808_abnormal_hematopoietic_stem | 0.49464855 |
135 | MP0002928_abnormal_bile_duct | 0.47652803 |
136 | MP0005084_abnormal_gallbladder_morpholo | 0.46640552 |
137 | MP0008260_abnormal_autophagy | 0.45781516 |
138 | MP0008872_abnormal_physiological_respon | 0.45033502 |
139 | MP0005535_abnormal_body_temperature | 0.43505597 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Stomatitis (HP:0010280) | 5.59287759 |
2 | IgG deficiency (HP:0004315) | 4.80787499 |
3 | Retrobulbar optic neuritis (HP:0100654) | 4.50162848 |
4 | Optic neuritis (HP:0100653) | 4.50162848 |
5 | Stomach cancer (HP:0012126) | 4.37277595 |
6 | Severe combined immunodeficiency (HP:0004430) | 4.25723152 |
7 | Abnormality of T cells (HP:0002843) | 4.12710875 |
8 | Recurrent fungal infections (HP:0002841) | 4.01270809 |
9 | Abnormality of B cell number (HP:0010975) | 3.79942969 |
10 | Spontaneous hematomas (HP:0007420) | 3.79874665 |
11 | Systemic lupus erythematosus (HP:0002725) | 3.77663981 |
12 | Abnormality of T cell physiology (HP:0011840) | 3.76983652 |
13 | Mediastinal lymphadenopathy (HP:0100721) | 3.76430601 |
14 | Complement deficiency (HP:0004431) | 3.74362541 |
15 | Abnormality of eosinophils (HP:0001879) | 3.63825120 |
16 | Granulocytopenia (HP:0001913) | 3.54269420 |
17 | B lymphocytopenia (HP:0010976) | 3.47557092 |
18 | Gastrointestinal infarctions (HP:0005244) | 3.47376760 |
19 | Pustule (HP:0200039) | 3.45800222 |
20 | Abnormality of the prostate (HP:0008775) | 3.40600266 |
21 | Leukocytosis (HP:0001974) | 3.37737955 |
22 | Pulmonary infiltrates (HP:0002113) | 3.33401832 |
23 | Eosinophilia (HP:0001880) | 3.32384589 |
24 | Encephalitis (HP:0002383) | 3.31451070 |
25 | Prostate neoplasm (HP:0100787) | 3.30130502 |
26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.25275668 |
27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.25275668 |
28 | Combined immunodeficiency (HP:0005387) | 3.15990770 |
29 | Autoimmune hemolytic anemia (HP:0001890) | 3.12190086 |
30 | Increased IgE level (HP:0003212) | 3.07269511 |
31 | Obstructive lung disease (HP:0006536) | 3.06638288 |
32 | Chronic obstructive pulmonary disease (HP:0006510) | 3.06638288 |
33 | Abnormality of macrophages (HP:0004311) | 3.00467074 |
34 | Agammaglobulinemia (HP:0004432) | 2.91279040 |
35 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.88843944 |
36 | Glomerulonephritis (HP:0000099) | 2.88118295 |
37 | Increased IgM level (HP:0003496) | 2.87212788 |
38 | Chronic otitis media (HP:0000389) | 2.86400246 |
39 | Deep venous thrombosis (HP:0002625) | 2.83242836 |
40 | Chest pain (HP:0100749) | 2.75135675 |
41 | Hemoptysis (HP:0002105) | 2.74422427 |
42 | Exercise-induced myalgia (HP:0003738) | 2.73776000 |
43 | Recurrent abscess formation (HP:0002722) | 2.72256420 |
44 | Amyloidosis (HP:0011034) | 2.70391554 |
45 | Recurrent bacterial skin infections (HP:0005406) | 2.68682054 |
46 | Thyroiditis (HP:0100646) | 2.67889750 |
47 | Joint swelling (HP:0001386) | 2.64217550 |
48 | Hyperlipoproteinemia (HP:0010980) | 2.63288627 |
49 | Abnormality of complement system (HP:0005339) | 2.62230660 |
50 | Arterial thrombosis (HP:0004420) | 2.61447116 |
51 | Lymphopenia (HP:0001888) | 2.60785204 |
52 | Joint hemorrhage (HP:0005261) | 2.58363126 |
53 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.55637690 |
54 | Cerebral hemorrhage (HP:0001342) | 2.54641829 |
55 | Xanthomatosis (HP:0000991) | 2.53329094 |
56 | Epiphyseal dysplasia (HP:0002656) | 2.52476984 |
57 | Autoimmune thrombocytopenia (HP:0001973) | 2.51603161 |
58 | Recurrent bronchitis (HP:0002837) | 2.48647409 |
59 | Purpura (HP:0000979) | 2.48040087 |
60 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.46338223 |
61 | Epistaxis (HP:0000421) | 2.43866931 |
62 | Recurrent sinusitis (HP:0011108) | 2.43444114 |
63 | Urticaria (HP:0001025) | 2.42258895 |
64 | Abnormality of the nasal mucosa (HP:0000433) | 2.39682956 |
65 | Colitis (HP:0002583) | 2.37685822 |
66 | Arthropathy (HP:0003040) | 2.37155542 |
67 | Mitral stenosis (HP:0001718) | 2.36864157 |
68 | Gangrene (HP:0100758) | 2.35835937 |
69 | Pulmonary embolism (HP:0002204) | 2.34993129 |
70 | Prolonged bleeding time (HP:0003010) | 2.33094606 |
71 | Myositis (HP:0100614) | 2.32502917 |
72 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.32493918 |
73 | Glomerulopathy (HP:0100820) | 2.32273386 |
74 | Alveolar cell carcinoma (HP:0006519) | 2.29276544 |
75 | Hypergammaglobulinemia (HP:0010702) | 2.28713235 |
76 | Vacuolated lymphocytes (HP:0001922) | 2.28679810 |
77 | Eczematoid dermatitis (HP:0000976) | 2.28106824 |
78 | Abnormal tarsal ossification (HP:0008369) | 2.26885813 |
79 | Anorexia (HP:0002039) | 2.25881012 |
80 | Gingival bleeding (HP:0000225) | 2.25140534 |
81 | Abnormality of the pleura (HP:0002103) | 2.24020573 |
82 | Inflammation of the large intestine (HP:0002037) | 2.22455953 |
83 | Abnormal foot bone ossification (HP:0010675) | 2.22130275 |
84 | Facial diplegia (HP:0001349) | 2.21029602 |
85 | Hematochezia (HP:0002573) | 2.20633599 |
86 | Growth hormone excess (HP:0000845) | 2.20331794 |
87 | Gastrointestinal stroma tumor (HP:0100723) | 2.20108994 |
88 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.19883976 |
89 | Pulmonary fibrosis (HP:0002206) | 2.17551251 |
90 | Episodic fever (HP:0001954) | 2.16150173 |
91 | Intrahepatic cholestasis (HP:0001406) | 2.14357769 |
92 | Muscle fiber inclusion bodies (HP:0100299) | 2.14315807 |
93 | Abnormality of male internal genitalia (HP:0000022) | 2.13361896 |
94 | Cellulitis (HP:0100658) | 2.13347228 |
95 | Recurrent skin infections (HP:0001581) | 2.12744681 |
96 | Chronic diarrhea (HP:0002028) | 2.12440911 |
97 | Prolonged partial thromboplastin time (HP:0003645) | 2.11886282 |
98 | Hypochromic anemia (HP:0001931) | 2.11120395 |
99 | Vertigo (HP:0002321) | 2.09543816 |
100 | Papilledema (HP:0001085) | 2.08742005 |
101 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.08280306 |
102 | Osteomyelitis (HP:0002754) | 2.08190971 |
103 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.08099390 |
104 | IgM deficiency (HP:0002850) | 2.07633590 |
105 | Nemaline bodies (HP:0003798) | 2.07068715 |
106 | Keratitis (HP:0000491) | 2.06315083 |
107 | Interstitial pulmonary disease (HP:0006530) | 2.05582840 |
108 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.03901640 |
109 | Abnormality of the common coagulation pathway (HP:0010990) | 2.03760284 |
110 | Muscle fiber splitting (HP:0003555) | 2.02171364 |
111 | Abnormality of the lumbar spine (HP:0100712) | 2.00939532 |
112 | Asymmetric septal hypertrophy (HP:0001670) | 2.00362590 |
113 | Skin rash (HP:0000988) | 2.00266997 |
114 | Gastrointestinal inflammation (HP:0004386) | 1.97285717 |
115 | Arthralgia (HP:0002829) | 1.96622249 |
116 | Sepsis (HP:0100806) | 1.96106304 |
117 | Meningitis (HP:0001287) | 1.95927825 |
118 | Restrictive lung disease (HP:0002091) | 1.95137054 |
119 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.95016713 |
120 | Neutropenia (HP:0001875) | 1.93968798 |
121 | Fatigue (HP:0012378) | 1.92109620 |
122 | Stridor (HP:0010307) | 1.90760675 |
123 | Dysostosis multiplex (HP:0000943) | 1.89948004 |
124 | Nephritis (HP:0000123) | 1.88946132 |
125 | Type 1 muscle fiber predominance (HP:0003803) | 1.88726147 |
126 | Panhypogammaglobulinemia (HP:0003139) | 1.87797999 |
127 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.87705736 |
128 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.87574607 |
129 | Bronchitis (HP:0012387) | 1.87484036 |
130 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.86725744 |
131 | Verrucae (HP:0200043) | 1.86353370 |
132 | Papilloma (HP:0012740) | 1.86353370 |
133 | Hepatosplenomegaly (HP:0001433) | 1.85870326 |
134 | Polycythemia (HP:0001901) | 1.85823069 |
135 | Gingivitis (HP:0000230) | 1.85277034 |
136 | Exercise-induced muscle cramps (HP:0003710) | 1.84915250 |
137 | Keratoconjunctivitis sicca (HP:0001097) | 1.84062337 |
138 | Myocardial infarction (HP:0001658) | 1.83305264 |
139 | Recurrent viral infections (HP:0004429) | 1.81789688 |
140 | Muscle stiffness (HP:0003552) | 1.81284822 |
141 | Abnormal platelet function (HP:0011869) | 1.81030723 |
142 | Impaired platelet aggregation (HP:0003540) | 1.81030723 |
143 | Barrel-shaped chest (HP:0001552) | 1.80127158 |
144 | Arterial tortuosity (HP:0005116) | 1.79619633 |
145 | Hypoalphalipoproteinemia (HP:0003233) | 1.78491476 |
146 | Calf muscle hypertrophy (HP:0008981) | 1.78043933 |
147 | Petechiae (HP:0000967) | 1.77385495 |
148 | T lymphocytopenia (HP:0005403) | 1.76966276 |
149 | Abnormality of T cell number (HP:0011839) | 1.76521114 |
150 | Vasculitis (HP:0002633) | 1.76485626 |
151 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.75798356 |
152 | Hyporeflexia of lower limbs (HP:0002600) | 1.75586579 |
153 | Orchitis (HP:0100796) | 1.74601784 |
154 | Steatorrhea (HP:0002570) | 1.73804122 |
155 | Abnormality of the frontal sinuses (HP:0002687) | 1.73615150 |
156 | Metaphyseal dysplasia (HP:0100255) | 1.72187837 |
157 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.71634158 |
158 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.70909068 |
159 | Ulnar deviation of the wrist (HP:0003049) | 1.70748512 |
160 | Fat malabsorption (HP:0002630) | 1.69152953 |
161 | Ketosis (HP:0001946) | 1.68946103 |
162 | Keratoconjunctivitis (HP:0001096) | 1.67879507 |
163 | Nasal polyposis (HP:0100582) | 1.66601007 |
164 | Abnormal platelet volume (HP:0011876) | 1.66444908 |
165 | Thoracic kyphosis (HP:0002942) | 1.66206067 |
166 | Microcytic anemia (HP:0001935) | 1.65931455 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TGFBR2 | 4.09742884 |
2 | MAP4K1 | 3.17059125 |
3 | RIPK4 | 3.05255262 |
4 | MAP2K2 | 2.71746811 |
5 | TIE1 | 2.70574641 |
6 | MAP2K3 | 2.40010970 |
7 | TEC | 2.08124371 |
8 | TXK | 1.96656230 |
9 | TYK2 | 1.93330054 |
10 | EPHB1 | 1.92940058 |
11 | FGFR4 | 1.83781417 |
12 | ITK | 1.75499145 |
13 | BTK | 1.71194261 |
14 | BCKDK | 1.70686298 |
15 | ERN1 | 1.65429047 |
16 | TESK2 | 1.63658201 |
17 | GRK7 | 1.61193246 |
18 | ZAP70 | 1.58559006 |
19 | KIT | 1.58195512 |
20 | STK10 | 1.54163872 |
21 | MYLK | 1.51356783 |
22 | CSF1R | 1.49802059 |
23 | MAPK12 | 1.49195040 |
24 | BLK | 1.45803496 |
25 | BMPR2 | 1.45578701 |
26 | IKBKE | 1.40916294 |
27 | JAK3 | 1.39517607 |
28 | JAK1 | 1.36500747 |
29 | SIK3 | 1.35745520 |
30 | MAP3K14 | 1.33779429 |
31 | MAP3K3 | 1.33285523 |
32 | MUSK | 1.32807317 |
33 | NLK | 1.25683222 |
34 | TBK1 | 1.24106706 |
35 | PIK3CG | 1.23360131 |
36 | MST4 | 1.20051859 |
37 | CSK | 1.17729349 |
38 | OBSCN | 1.16777503 |
39 | GRK6 | 1.16728700 |
40 | PHKG1 | 1.16359171 |
41 | PHKG2 | 1.16359171 |
42 | MAP3K12 | 1.15686143 |
43 | TTN | 1.15243315 |
44 | MAPK15 | 1.11098603 |
45 | STK24 | 1.08965846 |
46 | MARK3 | 1.08808802 |
47 | TNK2 | 1.08157836 |
48 | PIM1 | 1.07332201 |
49 | SYK | 1.06899625 |
50 | STK39 | 1.06832702 |
51 | MAP3K13 | 1.06823329 |
52 | TLK1 | 1.04780896 |
53 | FGFR3 | 1.02200521 |
54 | TRPM7 | 1.01558605 |
55 | KDR | 0.98728511 |
56 | CAMK1D | 0.98659852 |
57 | IKBKB | 0.97820675 |
58 | MAPK7 | 0.97581516 |
59 | LCK | 0.97275262 |
60 | LMTK2 | 0.96382048 |
61 | IRAK1 | 0.93780000 |
62 | HCK | 0.93770719 |
63 | GRK1 | 0.93439081 |
64 | FGFR2 | 0.91448627 |
65 | CLK1 | 0.91175416 |
66 | OXSR1 | 0.91142907 |
67 | IRAK4 | 0.90842474 |
68 | NEK9 | 0.89230943 |
69 | PRPF4B | 0.89153742 |
70 | LRRK2 | 0.88559359 |
71 | MAPKAPK5 | 0.88065583 |
72 | PRKG2 | 0.86980325 |
73 | INSRR | 0.86859213 |
74 | MAP2K6 | 0.86356589 |
75 | SIK2 | 0.84495165 |
76 | MAPK4 | 0.83375259 |
77 | MAP3K7 | 0.82970020 |
78 | PIK3CA | 0.81396386 |
79 | CAMKK2 | 0.79623629 |
80 | CAMK1G | 0.78643279 |
81 | PDK1 | 0.78477026 |
82 | PRKCH | 0.75433106 |
83 | FES | 0.75081232 |
84 | PRKCQ | 0.75047621 |
85 | JAK2 | 0.74302100 |
86 | TAOK3 | 0.73935833 |
87 | TGFBR1 | 0.73687918 |
88 | CAMKK1 | 0.72279510 |
89 | TRIB3 | 0.71591178 |
90 | SIK1 | 0.69494710 |
91 | SGK3 | 0.67001006 |
92 | MOS | 0.65581828 |
93 | PRKAA2 | 0.63779114 |
94 | CDK19 | 0.62917562 |
95 | EPHA3 | 0.62620357 |
96 | IGF1R | 0.61858282 |
97 | RPS6KA6 | 0.61214691 |
98 | RPS6KL1 | 0.61151317 |
99 | RPS6KC1 | 0.61151317 |
100 | LYN | 0.59985869 |
101 | IRAK3 | 0.59548194 |
102 | CDK4 | 0.59422933 |
103 | PDPK1 | 0.59303035 |
104 | MATK | 0.59263272 |
105 | MAP3K11 | 0.57994888 |
106 | PDK2 | 0.57960917 |
107 | PRKD1 | 0.57661107 |
108 | SGK494 | 0.57274785 |
109 | SGK223 | 0.57274785 |
110 | FLT3 | 0.55255546 |
111 | CHUK | 0.53469794 |
112 | PKN1 | 0.53210360 |
113 | RPS6KA2 | 0.52928778 |
114 | GRK5 | 0.51035985 |
115 | MAPK11 | 0.50795569 |
116 | MAP2K4 | 0.50780974 |
117 | HIPK2 | 0.50528703 |
118 | MAP3K1 | 0.49921934 |
119 | FYN | 0.49721130 |
120 | WNK1 | 0.49580451 |
121 | SGK2 | 0.49548560 |
122 | ARAF | 0.45241909 |
123 | ZAK | 0.45177680 |
124 | PRKD2 | 0.44113204 |
125 | MAP2K1 | 0.43940433 |
126 | MAPK3 | 0.43874750 |
127 | PASK | 0.42858912 |
128 | MAPKAPK2 | 0.42820412 |
129 | FGR | 0.42192681 |
130 | MARK2 | 0.41164046 |
131 | MAP4K2 | 0.40781831 |
132 | ABL1 | 0.40518123 |
133 | MAPKAPK3 | 0.39712115 |
134 | PINK1 | 0.39577456 |
135 | PTK2B | 0.35907666 |
136 | ADRBK2 | 0.32412407 |
137 | RPS6KA1 | 0.32147779 |
138 | PRKCD | 0.32088053 |
139 | EIF2AK2 | 0.29621603 |
140 | DAPK2 | 0.26721098 |
141 | IRAK2 | 0.25738011 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Allograft rejection_Homo sapiens_hsa05330 | 3.19930304 |
2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.12737894 |
3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.79813884 |
4 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.74136542 |
5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.65812251 |
6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.45627304 |
7 | Asthma_Homo sapiens_hsa05310 | 2.44784754 |
8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.31553705 |
9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.26141989 |
10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.19379768 |
11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.05175270 |
12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.01139101 |
13 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.99817103 |
14 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.97098447 |
15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.96271824 |
16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.76479816 |
17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.75754265 |
18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.69290568 |
19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.67815287 |
20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.66486503 |
21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.63481056 |
22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.61735390 |
23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.61184910 |
24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.59420714 |
25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.56993589 |
26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.52135042 |
27 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.52064572 |
28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.48263041 |
29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.44803367 |
30 | Peroxisome_Homo sapiens_hsa04146 | 1.44607440 |
31 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.41920260 |
32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.27081988 |
33 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.26244731 |
34 | Leishmaniasis_Homo sapiens_hsa05140 | 1.24307183 |
35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.21955498 |
36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.21808549 |
37 | Other glycan degradation_Homo sapiens_hsa00511 | 1.21258443 |
38 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.20527745 |
39 | ABC transporters_Homo sapiens_hsa02010 | 1.19417874 |
40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.15224808 |
41 | Influenza A_Homo sapiens_hsa05164 | 1.14823750 |
42 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.13219204 |
43 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.11858077 |
44 | Legionellosis_Homo sapiens_hsa05134 | 1.08775170 |
45 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.06828621 |
46 | Platelet activation_Homo sapiens_hsa04611 | 1.05596173 |
47 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.05262872 |
48 | Retinol metabolism_Homo sapiens_hsa00830 | 1.02897925 |
49 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.01375540 |
50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98216202 |
51 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.97382160 |
52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.96617654 |
53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92763229 |
54 | Pertussis_Homo sapiens_hsa05133 | 0.91871207 |
55 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.91069812 |
56 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.88863299 |
57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.88821551 |
58 | Hepatitis B_Homo sapiens_hsa05161 | 0.88736857 |
59 | Apoptosis_Homo sapiens_hsa04210 | 0.87357767 |
60 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.85805825 |
61 | Bile secretion_Homo sapiens_hsa04976 | 0.85795970 |
62 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.84778035 |
63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.81829751 |
64 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.81083609 |
65 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.78123143 |
66 | Lysosome_Homo sapiens_hsa04142 | 0.77615961 |
67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76657869 |
68 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.75959847 |
69 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.75583810 |
70 | Insulin resistance_Homo sapiens_hsa04931 | 0.75216785 |
71 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.74616444 |
72 | Malaria_Homo sapiens_hsa05144 | 0.74308251 |
73 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.73986126 |
74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73676307 |
75 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.73051609 |
76 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72459815 |
77 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.72166262 |
78 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71214631 |
79 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.70936354 |
80 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.70889637 |
81 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.70798452 |
82 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69499921 |
83 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.69321059 |
84 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.66639260 |
85 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.66425905 |
86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65512374 |
87 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62686993 |
88 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.62390420 |
89 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.59763716 |
90 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.59550421 |
91 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.59319443 |
92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.58806871 |
93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58490685 |
94 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.58108303 |
95 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56918194 |
96 | Measles_Homo sapiens_hsa05162 | 0.56730892 |
97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54782028 |
98 | Circadian rhythm_Homo sapiens_hsa04710 | 0.54272323 |
99 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.54183614 |
100 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.53807835 |
101 | Phagosome_Homo sapiens_hsa04145 | 0.53729330 |
102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52246691 |
103 | Endocytosis_Homo sapiens_hsa04144 | 0.51195318 |
104 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.50351083 |
105 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50088865 |
106 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49055334 |
107 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.48903440 |
108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47991160 |
109 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.47766071 |
110 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.46776383 |
111 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.45029707 |
112 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44876260 |
113 | Hepatitis C_Homo sapiens_hsa05160 | 0.43982862 |
114 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43935041 |
115 | Salmonella infection_Homo sapiens_hsa05132 | 0.43856865 |
116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43271066 |
117 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.43189234 |
118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42991375 |
119 | Shigellosis_Homo sapiens_hsa05131 | 0.42085751 |
120 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.41949610 |
121 | Focal adhesion_Homo sapiens_hsa04510 | 0.40763043 |
122 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.39705153 |
123 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.38318614 |
124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38114278 |
125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38011373 |
126 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.37893776 |
127 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.37782363 |
128 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.37265781 |
129 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.36303937 |
130 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.36141866 |
131 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.34969851 |
132 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34087084 |
133 | Tuberculosis_Homo sapiens_hsa05152 | 0.33908896 |
134 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.33776357 |
135 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33623051 |
136 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.33324318 |
137 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.32953821 |
138 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.32745247 |
139 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.32657249 |
140 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.32171799 |
141 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.32095107 |
142 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.31874805 |
143 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.31032768 |
144 | Renin secretion_Homo sapiens_hsa04924 | 0.30050778 |
145 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.29920175 |
146 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.27501311 |
147 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24918737 |
148 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.23034060 |
149 | Colorectal cancer_Homo sapiens_hsa05210 | 0.22340849 |
150 | Olfactory transduction_Homo sapiens_hsa04740 | 0.21973807 |
151 | Morphine addiction_Homo sapiens_hsa05032 | 0.20410478 |
152 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.19155407 |